The ADVISE Study: Advanced Visualization In Corneal Surgery Evaluation Intra-operative Optical Coherence Tomography in Posterior Lamellar Keratoplasty
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Fuchs Dystrophy
- Sponsor
- UMC Utrecht
- Enrollment
- 65
- Locations
- 3
- Primary Endpoint
- rate of the most relevant post-operative surgical complications
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
Rationale: Intra-operative optical coherence tomography (iOCT) is a new technology that incorporates advanced imaging techniques in the ophthalmic operating theatre. This allows surgeons to visualize tissues in a way previously impossible We conceptualized an iOCT-guided surgical protocol for the treatment of endothelial cell dysfunction, that refrains from the current practice of over-pressurizing the eye at the end of surgery.
Objective: The aim of this study is to assess the clinical value of intraoperative OCT (iOCT) for Descemet Membrane Endothelial Keratoplasty (DMEK) by comparing an iOCT-optimized surgical protocol with current practice, where the eye is over-pressurized for a set period of time, in terms of surgical efficiency, clinical outcomes, and adverse events.
Study design: International multicentre non-inferiority randomized clinical trial Study population: Patients scheduled for posterior lamellar corneal surgery for endothelial cell dysfunction above the age of 18 years.
Intervention: Both groups will undergo Descemet Membrane Endothelial Keratoplasty. Patients will be randomized for either the iOCT optimized surgical protocol or current standard surgical protocol using 8 minutes of overpressure to facilitate graft adherence. Both groups will be evaluated with iOCT at the end of surgery.
Main study parameters/endpoints:
The main study parameter is the rate of adverse events (particularly graft dislocations). Secondary parameters/endpoints are surgical time, the recovery of visual acuity and endothelial graft quality at 3 and 6 months follow-up, and a detailed evaluation of the extent/duration of surgical tissue manipulations.
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The use of iOCT during surgery does not entail additional risk to the patient. Participants to this study will adhere to the standard of care after corneal transplant surgery. In addition, they will receive study specific measurements and questionnaires. The additional measurements and questionnaires will be combined with regular follow up moments.
Investigators
Robert P.L. Wisse, MD PhD
academic staff member
UMC Utrecht
Eligibility Criteria
Inclusion Criteria
- •Age ≥ 18 years
- •Irreversible corneal decompensation caused by Fuchs corneal endothelial dystrophy or pseudophakic bullous keratopathy
- •Eligible for posterior lamellar keratoplasty, specifically Descemet Membrane Endothelial Keratoplasty (DMEK)
Exclusion Criteria
- •Any ocular co-morbidity other than cataract, mild dry eye disease, ocular hypertension, simple primary open angle glaucoma, and mild age-related macular degeneration
- •Prior corneal transplant surgery
- •Human leukocyte antigen (HLA) matched keratoplasty
- •Any disability that will interfere with performing or understanding the procedures and questionnaire fulfilment except if it is temporary of nature.
- •Combined phaco-emulsification-DMEK surgery (triple procedure)
Outcomes
Primary Outcomes
rate of the most relevant post-operative surgical complications
Time Frame: within 6 weeks post-operatively
the number of patients that develop adverse events relating to lamellar corneal surgery, specifically graft detachments that necessitate a surgical intervention, early graft failures that lead to intractable corneal edema, or induced iatrogenic acute glaucoma
Secondary Outcomes
- Surgical manipulations(during surgery)
- Surgical time(during surgery)
- Best-corrected visual acuity(3 and 6 months follow-up)
- Graft endothelial cell densities(3 and 6 months follow-up)